When patients are found to have elevated non-HDL cholesterol, ApoB-100 or LDL particle concentrations, they are presumed to be at increased risk and are often prescribed more aggressive lipid ...

non-HDL cholesterol (HDL-C) is a secondary target of therapy after the LDL-C goal has been achieved. Non-HDL-C concentration is highly correlated, but may be discordant with that of ApoB.

Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...

Using cryo-electron microscopy and AI, researchers at the University of Missouri have mapped ApoB100, a key protein in LDL ...

Apolipoprotein B concentration is the strongest lipid-associated predictor of cardiovascular events. However, in patients who require lipid-lowering therapy, LDL cholesterol is the primary ...